188 related articles for article (PubMed ID: 11730996)
21. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.
Eisbruch A; Ten Haken RK; Kim HM; Marsh LH; Ship JA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):577-87. PubMed ID: 10524409
[TBL] [Abstract][Full Text] [Related]
22. Novel protection strategy against X-ray-induced damage to salivary glands.
Nagler R; Marmary Y; Golan E; Chevion M
Radiat Res; 1998 Mar; 149(3):271-6. PubMed ID: 9496890
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced salivary dysfunction: clinical course and significance.
Valdez IH
Spec Care Dentist; 1991; 11(6):252-5. PubMed ID: 1813995
[TBL] [Abstract][Full Text] [Related]
24. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
25. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
[TBL] [Abstract][Full Text] [Related]
26. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy.
Braam PM; Roesink JM; Raaijmakers CP; Busschers WB; Terhaard CH
Radiat Oncol; 2007 Jan; 2():3. PubMed ID: 17207274
[TBL] [Abstract][Full Text] [Related]
27. Reducing radiation-induced xerostomia with highly conformal radiotherapy techniques.
Eisbruch A
J Support Oncol; 2005; 3(3):201-2. PubMed ID: 15915821
[No Abstract] [Full Text] [Related]
28. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.
Li Y; Taylor JM; Ten Haken RK; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):660-9. PubMed ID: 17141973
[TBL] [Abstract][Full Text] [Related]
29. Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia.
Zhang Q; Wei YM; Qi YG; Li BS
Korean J Radiol; 2018; 19(2):328-333. PubMed ID: 29520191
[TBL] [Abstract][Full Text] [Related]
30. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
Forner L; Hyldegaard O; von Brockdorff AS; Specht L; Andersen E; Jansen EC; Hillerup S; Nauntofte B; Jensen SB
Oral Oncol; 2011 Jun; 47(6):546-51. PubMed ID: 21493124
[TBL] [Abstract][Full Text] [Related]
31. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
32. Making a meaningful difference for the patient.
Scarantino CW
J Support Oncol; 2005; 3(3):207-8. PubMed ID: 15915822
[No Abstract] [Full Text] [Related]
33. Assessment of post-radiotherapy salivary glands.
Cheng SC; Wu VW; Kwong DL; Ying MT
Br J Radiol; 2011 May; 84(1001):393-402. PubMed ID: 21511748
[TBL] [Abstract][Full Text] [Related]
34. Irradiation-induced changes in secretion and composition of rat saliva.
Vissink A; Konings AW; Ligeon EE; 's-Gravenmade EJ
J Biol Buccale; 1990 Mar; 18(1):3-8. PubMed ID: 1694842
[TBL] [Abstract][Full Text] [Related]
35. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT
World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of irradiated salivary gland function in patients with head and neck tumours treated with radiotherapy.
Baharudin A; Khairuddin A; Nizam A; Samsuddin AR
J Laryngol Otol; 2009 Jan; 123(1):108-13. PubMed ID: 18452635
[TBL] [Abstract][Full Text] [Related]
37. Long-term parotid gland function after radiotherapy.
Braam PM; Roesink JM; Moerland MA; Raaijmakers CP; Schipper M; Terhaard CH
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):659-64. PubMed ID: 15936542
[TBL] [Abstract][Full Text] [Related]
38. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
[TBL] [Abstract][Full Text] [Related]
39. [Functional scintigraphy of salivary glands of the head during telecobalt radiotherapy].
Cha IH; Ritzl F
Strahlentherapie; 1983 Nov; 159(11):690-4. PubMed ID: 6658857
[TBL] [Abstract][Full Text] [Related]
40. Pathophysiology and management of radiation-induced xerostomia.
Berk LB; Shivnani AT; Small W
J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
